リポペプチド系抗真菌剤ミカファンギンの工業化
スポンサーリンク
概要
- 論文の詳細を見る
The manufacturing process of Micafungin (1) which is a novel candin antifungal agent discovered and developed by Astellas Pharma Inc. was studied.<BR>A new asymmetric isoxazole ring formation which is key reaction for synthesis of side chain active ester 2 was developed via β-keto enamine intermediate.<BR>And also a reaction condition of selective acylation with FUN intermediate 3 and purification of Micafungin drug substance was investigated from the viewpoints of high quality and productivity.
- 社団法人 有機合成化学協会の論文
- 2006-12-01